Drug and Medication Analysis & Statistics, March 2013 (p10)

China Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

Includes 3 FREE quarterly updates BMI View: 2012 is a very important year for the country as the government look to carry on their achievements following the healthcare reform in 2009. We highlight that ...

Industries : Drug and Medication
Countries : China

Taiwan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: While high volume consumption of pharmaceuticals per capita will continue to draw multinationals to Taiwan, the country remains committed to cost-containment in the public healthcare spending ...

Industries : Drug and Medication
Countries : Taiwan

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Despite an increasingly ageing population (consequently increasing burden of noncommunicable diseases) Hong Kong will only be moderately attractive to investors given its small industry size. ...

Industries : Drug and Medication
Countries : United States

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Despite a contraction in pharmaceutical prices, Latvia's pharmaceutical industry performed strongly in first nine months of 2011, which has led to upward revisions to our outlook for 2011 and ...

Industries : Drug and Medication
Countries : Latvia

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals relative to other Western Europe ...

Industries : Drug and Medication
Countries : Netherlands

Oman Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Oman's 2012 budget allocated a greater sum of money to the healthcare segment, in line with BMI's view that the Arab spring would lead to greater spending in this sector . The Omani government ...

Industries : Drug and Medication
Countries : Oman

New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: New Zealand has slipped ranks in our latest Risk/Reward Ratings - falling behind India due to the fact its small pharmaceutical industry is not as attractive as India's industry for multinational ...

Industries : Drug and Medication
Countries : New Zealand

Kuwait Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: While Kuwait will continue to be of interest to multinational drugmakers - on account of traditional preference for branded medicines and the population's wealth - we caution that strengthening ...

Industries : Drug and Medication
Countries : Kuwait

Japan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
February 2013
by Business Monitor International

BMI View: Japan's pharmaceutical industry is highly attractive to both foreign and local drugmakers. All three sub-sectors - patented, generic and over-the-counter (OTC) medicines - are large and projection ...

Industries : Drug and Medication
Countries : Japan

Canada Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
February 2013
by Business Monitor International

BMI View: With Canada's economy set to weather the external storm, the outlook for the country's pharmaceutical industry looks relatively stable. Over the longer-term an ageing population in this already ...

Industries : Drug and Medication
Countries : Canada

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
February 2013
by Business Monitor International

BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measures have taken their toll on all segments - including the pharmaceutical and healthcare market . Following ...

Industries : Drug and Medication
Countries : Portugal

Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
February 2013
by Business Monitor International

BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare segment . In particular, draft ...

Industries : Drug and Medication
Countries : Romania

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
February 2013
by Business Monitor International

BMI View: Singapore is a well-developed pharmaceutical industry, although overall revenues only reached a modest SGD901mn (US Dollar 716mn) in 2011, on account of the small population of the city-state. ...

Industries : Drug and Medication
Countries : Singapore

Italy Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
February 2013
by Business Monitor International

BMI View: The pharmaceuticals and healthcare segment will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highlights ...

Industries : Drug and Medication
Countries : Italy

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical industry, representing moderately good news for drugmakers. However, this development will ...

Industries : Drug and Medication
Countries : Hungary

Egypt Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: While Egypt's healthcare and pharmaceuticals market outlook continues to be dominated by macroeconomic themes, such as currency depreciation and political risk stemming from the upcoming Shura ...

Industries : Drug and Medication
Countries : Egypt

Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: While we continue to see huge potential in the Ukrainian pharmaceutical industry, we are pessimistic with regard to short- and medium-term stability in the industry place. In particular, we ...

Industries : Drug and Medication
Countries : Ukraine

Malaysia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Malaysia's longer term potential as an attractive pharmaceutical industry will remain shaped by the prevailing economic conditions and the export situation, which are crucial for the country's ...

Industries : Drug and Medication
Countries : Malaysia

Vietnam Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The attractiveness of the Vietnamese pharmaceutical industry to foreign investors will continue to be hampered by the country's poor enforcement of intellectual ...

Industries : Drug and Medication
Countries : Vietnam

Thailand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Thailand is a moderately attractive pharmaceutical industry for multinationals. On the positive side, rewards are potentially considerable, given the country's epidemiological profile and the ...

Industries : Drug and Medication
Countries : Thailand

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While Ghana's business environment is superior to that of almost all of its neighbours in West and Central Africa, its domestic industry is relatively small ...

Industries : Drug and Medication
Countries : Ghana

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Brazil remains the most attractive emerging pharmaceutical industry in the Americas due to its large population, strong consumer demand, increasing urbanisation ...

Industries : Drug and Medication
Countries : Brazil

Finland Pharmaceuticals and Healthcare Report Q2 2013

$ 1 088
Industry report
March 2013
by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While Finland's pharmaceutical market is small compared with its Western European neighbours, BMI believes the country's high public expenditure on health and ...

Industries : Drug and Medication
Countries : Finland

Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The challenges facing drugmakers in Greece in 2012 will be considerably tougher than those faced in 2011. With the introduction of new cost-containment legislation ...

Industries : Drug and Medication
Countries : Greece

Lebanon Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Continued improvement in Lebanon's intellectual property (IP) and pharmaceutical regulatory environment reinforces BMI's view that the country will begin to attract investment in a similar fashion ...

Industries : Drug and Medication
Countries : Lebanon

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: The Kenyan pharmaceuticals and healthcare industry presents significant revenue-earning opportunities for drug firms . Growth in the segment will be boosted by strong demographics, increased ...

Industries : Drug and Medication
Countries : Kenya

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections ...

Industries : Drug and Medication
Countries : Slovenia

Sweden Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Sweden's high public expenditure on health (SEK252bn, or US Dollar 39bn, in 2011), accounting for 79% of total healthcare expenditure) is a major factor in making it an attractive place to sell ...

Industries : Drug and Medication
Countries : Sweden

Pakistan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: Despite the fact a significant number of multinationals are present in Pakistan, and the country's significant industry potential, the leading international companies play a minimal role in ...

Industries : Drug and Medication
Countries : Pakistan

Tanzania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

$ 1 088
Industry report
March 2013
by Business Monitor International

BMI View: We are encouraged by the fact that the Tanzanian government has placed a greater emphasis on development expenditure, highlighting healthcare as a key area of investment, particularly as the ...

Industries : Drug and Medication
Countries : Tanzania